Read the full article here Follow Our Journey Stay updated on the latest insights and developments by following us on social media: LinkedIn | Twitter/X | Instagram
They are used, when appropriate, within a broader GLP-1 Weight Loss for Longevity framework that emphasizes body composition, metabolic health, protein adequacy, resistance training, cardiovascular risk reduction, and long-term maintenance
This process, known as antioxidant regeneration, is essential for maintaining long-term protection inside cells
We believe this oral GLP-1RA molecule could offer alternatives to current injectable therapies both as a potential monotherapy as well as in combination for cardiometabolic diseases such as type-2 diabetes, as well as for obesity, Sharon Barr, AstraZenecas executive vice president of biopharmaceuticals R&D, said in a statement